Date | Open | Close | Daily High | Daily Low |
---|
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
01/31/25 | Stephens Inc. | Maintained Hold | $13 | |||
03/19/24 | Deutsche Bank | Downgraded to Hold | $10 | |||
01/19/24 | RBC Capital Markets | Maintained Buy | $11 | |||
01/03/24 | Barclays Capital | Maintained Hold | $11 | |||
11/14/23 | Stephens Inc. | Maintained Hold | $13 | |||
10/10/23 | Stephens Inc. | Maintained Hold | $13 | |||
07/06/23 | Argus Research Company | Downgraded to Hold |
2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|
Revenue | 615 | 585 | - | - |
Dividend | 0.00 | - | - | - |
Dividend Yield (in %) | 0.00 % | 0.00 % | - | - |
EPS | 0.29 | 0.29 | - | - |
P/E Ratio | 15.42 | 15.17 | 8.90 | 6.72 |
EBIT | 40 | 43 | - | - |
EBITDA | 82 | 75 | - | - |
Net Profit | 36 | 34 | - | - |
Net Profit Adjusted | 36 | 34 | - | - |
Pre-Tax Profit | 47 | 44 | - | - |
Pre-Tax Profit Reported | 36 | - | - | - |
EPS (Non-GAAP) ex. SOE | - | - | - | - |
EPS (GAAP) | -0.53 | 0.14 | - | - |
Gross Income | 331 | 331 | - | - |
Cash Flow from Investing | - | - | - | - |
Cash Flow from Operations | - | - | - | - |
Cash Flow from Financing | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Free Cash Flow | - | - | - | - |
Free Cash Flow per Share | - | - | - | - |
Book Value per Share | - | - | - | - |
Net Debt | -394 | - | - | - |
Research & Development Exp. | 117 | 117 | - | - |
Capital Expenditure | - | - | - | - |
Selling, General & Admin. Exp. | - | - | - | - |
Shareholder’s Equity | 1,435 | - | - | - |
Total Assets | - | - | - | - |
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 12/31/25 |
Next Year ending 12/31/26 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 1 | 1 | 2 | 1 |
Average Estimate | - | 0.070 USD | 0.080 USD | 0.285 USD | 0.290 USD |
Year Ago | - | - | - | - | - |
Publish Date | - | - | - | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 2 | 2 | 3 | 1 |
Average Estimate | - | 152 USD | 157 USD | 615 USD | 585 USD |
Year Ago | - | - | - | - | - |
Publish Date | - | - | - | - | - |
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|
Sales | 588.02 | 1,503.04 | 1,502.70 | 1,771.68 | 1,749.96 | 1,806.34 | 1,549.90 |
Change of sales in % | -60.88 | 0.02 | -15.18 | 1.24 | -3.12 | 16.55 | 11.79 |
Gross profit on sales | 234.09 | 575.35 | 516.24 | 686.24 | 697.79 | 747.50 | 645.03 |
Gross profit on sales change in % | -59.31 | 11.45 | -24.77 | -1.66 | -6.65 | 15.89 | 15.72 |
Operating income | -19.17 | 87.03 | -57.66 | 8.47 | -20.74 | 39.26 | 67.99 |
Operating income change in % | - | - | - | - | - | -42.26 | 74.62 |
Income before tax | -63.85 | 161.83 | -149.31 | -206.52 | 13.14 | -209.62 | -14.78 |
Income before tax change in % | - | - | 27.70 | - | - | -1,317.87 | - |
Income after tax | -20.04 | 133.98 | -132.62 | -182.18 | -31.40 | -201.14 | -25.65 |
Income after tax change in % | - | - | 27.20 | -480.22 | 84.39 | -684.09 | -1,052.38 |
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|
Total liabilities | 487.22 | 1,017.09 | 1,251.38 | 1,920.55 | 1,601.06 | 2,638.54 | 2,171.27 |
Long-term liabilities per share | 2.42 | 4.05 | 2.26 | 4.37 | 4.69 | 9.79 | 8.33 |
Equity | 1,017.51 | 1,408.14 | 1,666.24 | 1,285.19 | 1,580.43 | 1,591.61 | 1,660.89 |
Equity change in % | -27.74 | -15.49 | 29.65 | -17.14 | 38.38 | -9.05 | -12.46 |
Balance sheet total | 1,504.72 | 2,425.23 | 2,917.62 | 3,205.74 | 3,181.48 | 4,230.15 | 3,832.16 |
Balance sheet total change in % | -37.96 | -16.88 | -8.99 | 0.76 | -24.79 | 10.39 | 42.89 |
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|
Sales per share | 5.25 | 10.84 | 9.43 | 10.65 | 9.94 | 9.99 | 8.32 |
P/E ratio (year end quote, basic EPS) | - | 19.12 | - | - | - | - | - |
P/E ratio (year end quote, diluted EPS) | - | 19.12 | - | - | - | - | - |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity ratio in % | 67.62 | 58.06 | 57.11 | 40.09 | 49.68 | 37.63 | 43.34 |
Debt ratio in % | 32.38 | 41.94 | 42.89 | 59.91 | 50.32 | 62.37 | 56.66 |
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Vakharia Tejal | 06/01/2025 | 69,768.00 | 387,476.00 | 4.30 | Buy | No |
Hammond Lisa | 06/01/2025 | 58,140.00 | 174,175.00 | 4.30 | Buy | No |
Hammond Lisa | 05/08/2025 | 2,087.00 | 117,561.00 | 4.30 | Sell | No |
Vakharia Tejal | 05/08/2025 | 3,169.00 | 317,708.00 | 4.30 | Sell | No |
Langan Thomas | 05/01/2025 | 1,893.00 | 327,528.00 | 4.40 | Sell | No |
Langan Thomas | 03/31/2025 | 2,481.00 | 329,421.00 | 4.25 | Sell | No |
Hammond Lisa | 03/31/2025 | 227.00 | 119,648.00 | 4.25 | Sell | No |
ASAR VINIT K | 03/23/2025 | 10,112.00 | 10,112.00 | n/a | Buy | No |
SILVERMAN LOU | 03/23/2025 | 10,112.00 | 10,112.00 | n/a | Buy | No |
Felt Bruce C. Jr. | 03/23/2025 | 8,696.00 | 8,696.00 | n/a | Buy | No |
Vakharia Tejal | 09/02/2024 | 1,223.00 | 320,877.00 | 9.61 | Sell | No |
Garrison Greg | 05/30/2024 | 6,179.00 | 75,443.00 | 9.50 | Sell | No |
Garrison Greg | 05/30/2024 | 21,053.00 | 81,622.00 | n/a | Buy | No |
JUDGE JONATHAN | 05/30/2024 | 42,106.00 | 174,593.00 | n/a | Buy | No |
Altman Elizabeth Ann | 05/30/2024 | 42,106.00 | 77,658.00 | n/a | Buy | No |
Hammond Lisa | 05/24/2024 | 1,540.00 | 67,243.00 | 7.55 | Sell | No |
Hammond Lisa | 05/02/2024 | 2,105.00 | 68,783.00 | 7.70 | Sell | No |
Vakharia Tejal | 05/02/2024 | 3,169.00 | 258,942.00 | 7.70 | Sell | No |
Langan Thomas | 05/01/2024 | 1,893.00 | 174,007.00 | 7.80 | Sell | No |
Vakharia Tejal | 04/30/2024 | 4,301.00 | 262,111.00 | 7.82 | Sell | No |
Langan Thomas | 04/30/2024 | 9,354.00 | 175,900.00 | 7.82 | Sell | No |
Hammond Lisa | 03/31/2024 | 193.00 | 70,888.00 | 7.80 | Sell | No |
Vakharia Tejal | 03/01/2024 | 9,663.00 | 266,412.00 | 6.13 | Sell | No |
Vakharia Tejal | 03/01/2024 | 3,221.00 | 243,093.00 | 6.13 | Sell | No |
Vakharia Tejal | 03/01/2024 | 32,982.00 | 276,075.00 | n/a | Buy | No |
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2022 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2021 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2020 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2019 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2018 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2017 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2016 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2015 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2014 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2013 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2012 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2011 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2010 | Allscripts Healthcare Solutions Inc | 0.00 | 0.00 | USD |
2009 | Allscripts Healthcare Solutions Inc | 5.23 | 40.51 | USD |
Event | Estimate | Info | Date |
---|
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 0.120 USD | Q3 2022 Earnings Release | 11/03/2022 |
Earnings Report | -0.540 USD | Q2 2022 Earnings Release | 08/04/2022 |
Annual General Meeting | 0.970 USD | Annual General Meeting | 06/21/2022 |
Earnings Report | 0.170 USD | Q1 2022 Earnings Release | 05/05/2022 |
Earnings Report | 0.680 USD | Q4 2021 Earnings Release | 02/24/2022 |